Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

European Union

Brexit forum set up by community pharmacy negotiators

A Brexit forum representing community pharmacy and organisations involved in the medicines supply chain has been set up to share advice and information in the run-up to the UK leaving the EU.

The forum was set up by the community pharmacy negotiators, the Pharmaceutical Services Negotiating Committee (PSNC), following its meeting on 10—11 July 2018.

The move comes after the new health minister, Matt Hancock, said he was having talks with industry about the stockpiling medicines in case of a no-deal Brexit, and the parliamentary vote for the UK to have continued involvement in the European Medicines Agency after it leaves the EU.

The intention is that the Community Pharmacy Brexit Forum members will share information about the impact of Brexit on community pharmacy and the supply chain and offer best advice.

It will also liaise with the Department of Health and Social Care (DHSC) to make sure that the supply chain is maintained.

Its inaugural members are the chief executives from the National Pharmacy Association, the Company Chemists’ Association, the Association of Independent Multiple Pharmacies, the Royal Pharmaceutical Society, the Pharmacists’ Defence Association, the Dispensing Doctors Association and the Healthcare Distribution Association.

“We expect the DHSC, NHS England and the Medicines and Healthcare products Regulatory Agency to have contingency plans and to monitor the medicines supply market, during and after Brexit, but the forum will help to identify relevant issues and seek appropriate clarification as required, in the approach to the Brexit deadline,” said a statement from the PSNC.

Gordon Hockey, director of operations and support at the PSNC, told The Pharmaceutical Journal he is hopeful the new forum will help prevent any problems with the supply chain caused by a no-deal Brexit, but was unable to say which medicines could be in short supply.

“I think the key is to try and work from facts, rather than fears. There are all sorts of issues and what we don’t want to do now is to second guess them,” he said

“What we want to do is bring people together so that the issues can be discussed, and as a sector, we can liaise with the government and NHS England so that there is confidence in the supply chain, and that it does continue uninterrupted so that medicines get to patients.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205238

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.